JEADV Clinical Practice (Sep 2024)

Identification and functional validation of a novel pathogenic POT1 germline variant p.G95V in familial melanoma

  • Farrah Bakr,
  • Anjana Kulkarni,
  • Stephen Mounsey,
  • Tracey Mitchell,
  • Sean Whittaker,
  • Katie Lacy

DOI
https://doi.org/10.1002/jvc2.382
Journal volume & issue
Vol. 3, no. 4
pp. 1236 – 1239

Abstract

Read online

Abstract POT1 variants have been identified in familial melanoma (FM) as well as a number of other germline and somatic malignancies. The functional validation of variants identified from the screening of patients with melanoma gene susceptibility panels is key to understanding the clinical significance of identified variants. Here we report a novel, likely pathogenic POT1 missense variant (p.G95V) in FM and investigate its functional impact. We demonstrate loss of function owing to the inability of the mutant POT1 protein to bind telomeric DNA compared to its wild‐type counterpart. This study provides important functional validation of a novel POT1 variant in FM.

Keywords